Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Miller, Brian J., Andrew Mellor, and Peter Buckley. "Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses." Brain, behavior, and immunity 31 (2013): 82-89.

Holubova, Kristina, Marketa Chvojkova, Barbora Hrcka Krausova, Vojtech Vyklicky, Eva Kudova, Hana Chodounska, Ladislav Vyklicky, and Karel Vales. "Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia." Biomolecules 11, no. 7 (2021): 1026.

Pillinger, Toby, Emanuele F. Osimo, Stefan Brugger, Valeria Mondelli, Robert A. McCutcheon, and Oliver D. Howes. "A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis." Schizophrenia bulletin 45, no. 5 (2019): 1120-1133.

Dondé, Clément, Marine Mondino, Jérôme Brunelin, and Frédéric Haesebaert. "Sensory-targeted cognitive training for schizophrenia." Expert review of neurotherapeutics 19, no. 3 (2019): 211-225.

Stubbs, Brendon, Poonam Gardner-Sood, Shubulade Smith, Khalida Ismail, Kathryn Greenwood, Ross Farmer, and Fiona Gaughran. "Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis." Schizophrenia research 168, no. 1-2 (2015): 461-464.

Dickerson, Faith, Cassie Stallings, Andrea Origoni, Jennifer Schroeder, Emily Katsafanas, Lucy Schweinfurth, Christina Savage, Sunil Khushalani, and Robert Yolken. "Inflammatory markers in recent onset psychosis and chronic schizophrenia." Schizophrenia bulletin 42, no. 1 (2016): 134-141.

Bartzokis, George, Po H. Lu, Erika P. Raven, Chetan P. Amar, Nicole R. Detore, Alexander J. Couvrette, Jim Mintz et al. "Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia." Schizophrenia research 140, no. 1-3 (2012): 122-128.

Langham, Heather. "Social cognition deficits and violence in people with a diagnosis of schizophrenia." (2015).

Schifani, Christin. "Robustness of a neurodevelopmental animal model of schizophrenia: combining immune stimulation with glutamatergic insult." PhD diss., 2016.

Khandaker, Golam M., Stanley Zammit, Stephen Burgess, Glyn Lewis, and Peter B. Jones. "Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort." Brain, behavior, and immunity 69 (2018): 264-272.

Lee, Ellen E., Suzi Hong, Averria Sirkin Martin, Lisa T. Eyler, and Dilip V. Jeste. "Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables." The American Journal of Geriatric Psychiatry 25, no. 1 (2017): 50-61.

Ayatollahi, Arghavan, Sayna Bagheri, Amir Ashraf-Ganjouei, Kamyar Moradi, Mohammad-Reza Mohammadi, and Shahin Akhondzadeh. "Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?." Clinical neuropharmacology 43, no. 5 (2020): 139-145.

Ayatollahi, Arghavan, Sayna Bagheri, Amir Ashraf-Ganjouei, Kamyar Moradi, Mohammad-Reza Mohammadi, and Shahin Akhondzadeh. "Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?." Clinical neuropharmacology 43, no. 5 (2020): 139-145.

Bulzacka, Ewa, Laurent Boyer, Franck Schürhoff, Ophélia Godin, Fabrice Berna, Lore Brunel, Meja Andrianarisoa et al. "Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset." Schizophrenia bulletin 42, no. 5 (2016): 1290-1302.

Popova, Petia. "Adjusting deviant oscillatory dynamics in Schizophrenia via computerized-cognitive training." PhD diss., 2016.

Seeman, Philip. "Clozapine, a fast-off-D2 antipsychotic." ACS chemical neuroscience 5, no. 1 (2014): 24-29.

Perkovic, Matea Nikolac, Gordana Nedic Erjavec, Dubravka Svob Strac, Suzana Uzun, Oliver Kozumplik, and Nela Pivac. "Theranostic biomarkers for schizophrenia." International journal of molecular sciences 18, no. 4 (2017): 733.

Dorado Ramírez, Carlos Alberto, and Daniela Castaño Correa. "Effectiveness of Computerized Programs in Cognitive Rehabilitation of Patients with Schizophrenia." Pensamiento Psicológico 16, no. 2 (2018): 73-86.

Popova, Petia. "Adjusting deviant oscillatory dynamics in Schizophrenia via computerized-cognitive training." PhD diss., 2016.

Goto, Akihiro, Ichiro Nakahara, Takashi Yamaguchi, Yuji Kamioka, Kenta Sumiyama, Michiyuki Matsuda, Shigetada Nakanishi, and Kazuo Funabiki. "Circuit-dependent striatal PKA and ERK signaling underlies rapid behavioral shift in mating reaction of male mice." Proceedings of the National Academy of Sciences 112, no. 21 (2015): 6718-6723.